Big Tech's Nuclear Bet: Powering The AI Revolution
Google's partnership to build a small modular nuclear reactor highlights a pivotal shift in powering AI infrastructure. This theme focuses on the companies enabling the next generation of nuclear energy to meet Big Tech's surging electricity demands.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Alphabet Inc. - Class C Shares
GOOG
Current price
$204.29
Google's partnership to build an advanced nuclear reactor highlights the tech giant's commitment to securing clean, reliable power for its AI infrastr...
Google's partnership to build an advanced nuclear reactor highlights the tech giant's commitment to securing clean, reliable power for its AI infrastructure and data centres.
NuScale Power Corp
SMR
Current price
$34.98
NuScale Power is a leading developer of small modular reactor technology, positioned at the forefront of the next generation nuclear energy revolution...
NuScale Power is a leading developer of small modular reactor technology, positioned at the forefront of the next generation nuclear energy revolution.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Google's partnership with Kairos Power to build a small modular reactor represents a strategic shift by major tech companies toward securing reliable, zero-carbon baseload power for AI infrastructure. This move beyond traditional renewables signals the beginning of widespread nuclear adoption by the tech industry to meet surging electricity demands.
What You Need to Know
This group focuses on the advanced nuclear energy ecosystem, including developers of small modular reactors, uranium fuel cycle companies, and manufacturers of critical reactor components. The theme captures the entire value chain positioned to benefit from Big Tech's transition to nuclear power for data centres and AI operations.
Why These Stocks
These companies were handpicked by professional analysts as key players positioned to enable the energy transition for next-generation technological innovation. They represent exposure to the specialized nuclear supply chain that could see long-term growth as tech giants increasingly adopt nuclear solutions for their power needs.
Group Performance Snapshot
Stocks Rated Buy by Analysts
10 of 10 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Energy Revolution Underway
Google's nuclear partnership marks the beginning of a massive shift as tech giants seek reliable, clean power for AI infrastructure. This could trigger widespread adoption across the industry.
First-Mover Advantage
Companies in this space are positioned at the forefront of next-generation nuclear technology. Early players in small modular reactors and advanced fuel cycles could see substantial growth as demand accelerates.
AI Demands More Power
The explosive growth of artificial intelligence requires massive amounts of consistent, reliable electricity. Nuclear power offers the only scalable solution for zero-carbon baseload power that can meet these demands.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.